Skip to main content

Bahram Robert Oliai, MD

Pathologist, Director of UroDiagnostics

Board Certifications

Anatomic and Clinical Pathology, Cytopathology


Cytopathology, Surgical Pathology




ProPath, a Sonic Healthcare anatomic pathology practice, is pleased to include Bahram R. Oliai, M.D., as a part of its dynamic medical staff. Dr. Oliai brings extensive professional experience and a robust list of peer-reviewed publications. He is ProPath’s director of UroDiagnostics.

Dr. Oliai earned his medical degree from the University of Illinois College of Medicine in Rockford, IL. He served a residency in anatomic and clinical pathology at The Johns Hopkins Hospital in Baltimore, Maryland. He completed a fellowship in surgical pathology, also at The Johns Hopkins Hospital. This was followed by a cytopathology fellowship at Memorial Sloan Kettering Cancer Center in New York, New York. He has further speciality training in genitourinary pathology in Dr. Jonathan Epstein’s GU consult service in the Division of Genitourinary Pathology at The Johns Hopkins Hospital.

Dr. Oliai started as a pathologist at Associated Pathology Consultants in Elmhurst, Illinois, after his second fellowship. During this time, he was also the medical director of microbiology at Elmhurst Memorial Hospital. While at Elmhurst Memorial Hospital, he was a member of the infection control and LIS committees. Dr. Oliai has been a pathologist at ProPath in Dallas, Texas, since 2006. During this time, he has also held a teaching appointment at University of Texas Southwestern Medical Center in Dallas as a clinical assistant professor.

Dr. Oliai has a considerable amount of publications in peer-reviewed journals and two book chapters. He has published manuscripts in a wide variety of journals including the American Journal of Surgical Pathology, Head Neck Pathology, Human Pathology, and the International Journal of Surgical Pathology, among others. Dr. Oliai also has two book chapters, one on immunohistochemistry in Diagnostic Dermatopathology: A Guide to Ancillary Tests Beyond the H&E. The other is on the subject of renal pathology in Practical Renal Pathology: A Diagnostic Approach. He has published abstracts in Modern Pathology and presented at an annual meeting of the United States and Canadian Academy of Pathology, along with a web publication in Case Studies in Flow Cytometry.

Dr. Oliai is a member of several professional organizations. These include the Association of American Physicians and Surgeons, College of American Pathologists, the International Society of Urologic Pathology and the United States and Canadian Academy of Pathology.

Dr. Oliai holds full medical licensure and is board certified in cytopathology and anatomic and clinical pathology by the American Board of Pathology.



University of Illinois College of Medicine (MD)
Rockford, IL


Postgraduate Training

Cytopathology Fellowship
Memorial Sloan Kettering Cancer Center
New York, NY

Surgical Pathology Fellowship
The Johns Hopkins Hospital
Baltimore, MD

Anatomic and Clinical Pathology Residency
The Johns Hopkins Hospital
Baltimore, MD


Professional Memberships

Association of American Physicians and Surgeons
College of American Pathologists
International Society of Urologic Pathology
United States and Canadian Academy of Pathology


Peer-Reviewed Articles

  1. Rooper LM, Lombardo KA, Oliai BR, Ha PK, Bishop JA. MYB RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status. Am J Surg Pathol. 2021;45(4):488-497.

  2. Bishop JA, Koduru P, Veremis BM, Oliai BR, Weinreb I, Rooper LM, Dickson BC, Demicco EG. SS18 break-apart fluorescence in situ hybridization is a practical and effective method for diagnosing microsecretory adenocarcinoma of salivary glands. Head Neck Pathol. 2021 Sep;15(3):723-726.

  3. Rooper LM, Mansour M, Yonescu R, Oliai BR, Bishop JA, Westra WH. The decline of salivary adenocarcinoma not otherwise specified as a tumor entity: reclassification using contemporary immunohistochemical profiling and diagnostic criteria. Am J Surg Pathol. December 2020. doi:10.1097/PAS.0000000000001636. [Epub ahead of print]
  4. Rooper LM, Lester LD, Gagan J, Oliai BR, Weinreb I, Bishop JA. Salivary intraductal carcinoma arising within intraparotid lymph node: a report of 4 cases with identification of a novel STRN-ALK fusion. Head Neck Pathol. 2020 Jul 13. doi: 10.1007/s12105-020-01198-0. [Epub ahead of print]

  5. Xu X, Palsgrove D, Kurian E, Yan S, Oliai BR, Bishop JA. Variable expression of S100 protein in sinonasal malignant mucosal melanoma: a potential diagnostic pitfall. Head Neck Pathol. 2020 Apr 1. doi: 10.1007/s12105-020-01158-8. [Epub ahead of print]

  6. Daoud EV, McLean-Holden AC, Pfeifer CM, Timmons CF, Oliai BR, Bishop JA. Pediatric Warthin-like mucoepidermoid carcinoma: report of two cases with one persistent/recurrent as conventional mucoepidermoid carcinoma. Head Neck Pathol. 2020 Mar 27. doi: 10.1007/s12105-020-01156-w. [Epub ahead of print]

  7. Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, Thompson LDR. Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol. 2020;14(3):630-636.

  8. Kurian EM, Miller R, Mclean-Holden AL, Oliai BR, Bishop JA. Low molecular weight cytokeratin immunostaining for extrafollicular reticulum cells is an effective means of separating salivary gland tumor-associated lymphoid proliferation from true lymph node involvement. Head Neck Pathol. 2020;14(3):593-597.

  9. Shah AA, Oliai BR, Bishop JA. Consistent LEF-1 and MYB immunohistochemical expression in Human papillomavirus-related multiphenotypic sinonasal carcinoma: a potential diagnostic pitfall. Head Neck Pathol. 2019;13(2):220-224.

  10. Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, Sung YS, Chen CL, Oliai BR, Antonescu CR. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42(4):442-452.

  11. Ghisoli M, Rutledge M, Stephens PJ, Mennel R, Barve, M, Menley M, Oliai BR, Murphy KM, Manning L, Gutierez B, Rangadass P, Walker A, Wang Z, Rao D, Adams N, Wallraven G, Senzer N, Nemunaitis J. Case report: Immune-mediated complete response in a patient with recurrent advanced Ewing sarcoma (EWS) after vigil immunotherapy. J Pediatr Hematol Oncol. 2017;39(4):e183-e186.

  12. Sundarkrishnan L, Bradish JR, Oliai BR, Hosler GA. Cutaneous cellular pseudoglandular schwannoma: an unusual histopathologic variant. Am J Dermatopathol. 2016;38(4):315-318.

  13. Jeung JA, Cao D, Selli BW, Clapp WL, Oliai BR, Parwani AV, Allan RW. Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. Hum Pathol. 2011;42(10):1554-1561.

  14. Bovio IM, Allan RW, Oliai BR, Hampton T, Rush DS. Xp11.2 translocation renal carcinoma with placental metastasis: a case report. Int J Surg Pathol. 2011;19(1):80-83.

  15. Jenkins CP, Cardona DM, Bowers JN, Oliai BR, Allan RW, Normann SJ. The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch Pathol Lab Med. 2010;134(2):256-263.

  16. Buresh CJ, Oliai BR, Miller RT. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol. 2008;129(6):894-898.

  17. Oliai BR, Sheth S, Burroughs FH, Ali SZ. “Parapharyngeal space” tumors: a cytopathological study of 24 cases on fine-needle aspiration. Diagn Cytopathol. 2005;32(1):11-15.

  18. Oliai BR, Zakowski MF, Lin O. Hodgkin’s lymphoma associated with plasma cell neoplasia: cytological features and review of the literature. Diagn Cytopathol. 2005;33(3):181-186.

  19. Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate? An immunohistochemical study using high molecular weight cytokeratin (clone 34[beta]E12) antibody. Am J Surg Pathol. 2002;26(9):1151-1160.

  20. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol. 2001;25(6):794-801.

  21. Oliai BR, Tazelaar H, Lloyd R, Doria M, Trastek V. Leiomyosarcoma of the pulmonary veins. Am J Surg Pathol. 1999;23(9):1082-1088.

Book Chapters

  1. Lewin MR, Oliai BR. Immunohistochemistry: background. In: Hosler G, ed. Diagnostic Dermatopathology: A Guide to Ancillary Tests Beyond the H&E. London, England: JP Medical Publishers; 2016:57-60.

  2. Oliai BR, Cohen D. Optimal specimen handling and ancillary studies: renal neoplasia. In: Lager D, Abrahams N, eds. Practical Renal Pathology: A Diagnostic Approach. Philadelphia, PA: Elsevier Saunders; 2013.


  1. Oliai BR, Buresh CJ, Miller RT. Lack of reactivity with TdT in small cell carcinoma [abstract 2077]. Mod Pathol. 2013;26(suppl 2s):499A.

  2. Buresh CJ, Oliai BR, Miller RT. Reactivity with TdT in Merkel cell carcinoma [abstract 407]. Mod Pathol. 2008;21(suppl 1s):91A.

  3. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy (presentation). USCAP Annual Meeting, Atlanta, GA, 2001.